In a mouse model of human breast cancer, these nanoparticles improved the biostability of siRNA and preferentially accumulated at the tumor site due to pH-responsive properties, thus delivering siRNA to the cytoplasm and acting directly on CXCR4 transcripts, thereby significantly inhibiting CXCR4 protein expression in breast cancer cells. This evidence concerns the gene CXCR4 and breast cancer.